Edwards Lifesciences Corporation (VIE:EWLS)

Austria flag Austria · Delayed Price · Currency is EUR
73.24
-0.89 (-1.20%)
Last updated: Dec 2, 2025, 1:00 PM CET
9.99%
Market Cap 42.68B
Revenue (ttm) 5.01B
Net Income (ttm) 1.17B
Shares Out n/a
EPS (ttm) 1.99
PE Ratio 36.61
Forward PE 30.93
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 8
Open 73.04
Previous Close 74.13
Day's Range 73.04 - 73.24
52-Week Range 59.37 - 75.24
Beta n/a
RSI 54.08
Earnings Date Feb 13, 2026

About Edwards Lifesciences

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solution... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 1958
Employees 15,800
Stock Exchange Vienna Stock Exchange
Ticker Symbol EWLS
Full Company Profile

Financial Performance

In 2024, Edwards Lifesciences's revenue was $5.44 billion, an increase of 8.57% compared to the previous year's $5.01 billion. Earnings were $4.17 billion, an increase of 197.68%.

Financial numbers in USD Financial Statements

News

There is no news available yet.